Greenlight Guru Clinical vs. Clario eCOA

Medical device and diagnostics companies running clinical studies are often stuck configuring EDC software that was built for pharmaceutical trials and never designed around FDA, EU MDR, IVDR, or ISO 14155 requirements. Greenlight Guru Clinical solves that by being the only electronic data capture (EDC) system built from the ground up for medtech, so teams aren't reworking someone else's pharma template to fit a device study. Designed exclusively for medtech, Greenlight Guru Clinical combines an easy to use clinical data platform with industry leading customer service, so teams generate reliable, compliant clinical data with confidence. Get a single, validated platform covering the full lifecycle of a device or diagnostics study, including: Electronic Data Collection and eCRF design, with GCP compliant structures and built in audit trails ePRO/eCOA for patient and clinician reported outcomes, collected in person or remotely on any device eConsent for compliant, auditable enrollment Randomization (RTSM) for controlled and comparative studies PMCF Surveys for post market clinical follow up under EU MDR Adverse Events Reporting built into the platform Leading-edge, open API for connecting study data to other clinical or quality systems Greenlight Guru Clinical supports pre-market clinical investigations, post-market surveillance studies, registries, and human factors testing, and is used by both device and diagnostics manufacturers and by contract research organizations (CROs) that specialize in medtech. A validation package is included with every product update, removing the ongoing burden of software revalidation from the quality team. Every customer also gets a dedicated customer success manager with real medtech experience, not a generalist software account rep. For manufacturers already on Greenlight Guru's quality management system (QMS), Clinical extends into one connected platform spanning quality, product development, and clinical evidence.

Improve the robustness of your evidence by utilizing advanced electronic Patient-Reported Outcomes (ePRO) and electronic Clinical Reported Outcomes (eClinRO). These electronic assessments, collectively referred to as eCOA, effectively capture patients' emotions and functional capabilities during clinical trials. By adopting an electronic approach to clinical data collection, you ensure that the information gathered from patients is not only of superior quality but also adheres to necessary regulatory guidelines. Essentially, eCOA addresses the pitfalls associated with traditional paper diaries, such as readability issues, transcription errors, and data inconsistencies. Moreover, the FDA encourages the implementation of ePRO, which allows patients to express their health experiences through various questionnaires, potentially covering aspects like quality of life and daily activity levels. Conversely, clinician-reported outcomes involve assessments conducted by healthcare professionals, including evaluations such as physical examinations like the Psoriasis Area and Severity Index (PASI). Additionally, performance outcomes assess a patient's capability to perform specific tasks, including timed activities, thereby providing a holistic perspective on their health. In conclusion, embracing eCOA and its related strategies represents a significant advancement toward enhancing the reliability and efficiency of clinical trial methodologies, ultimately benefiting patient care. This shift not only streamlines data collection but also fosters greater patient engagement in their health management.